Menstrual Abnormalities
Menstrual Abnormalities
Menstrual Abnormalities
ABNORMALITIES
NORMAL MENSTRUATION
Menstruation
Menstruation, or period, is normal vaginal bleeding
40 ml)
Duration of flow 3-7 days
days)
Cycle length 21 - 35 days
days)
(average 4
(average 29
regulates by:
interaction between hypothalamus, ptuitary
and ovaries
Mean age of menarche and menopase are:
Menarche 12,7
Menapause 51,4
Hormones in menstrual
cycle
Gonadotrophin Releasing Hormone (GnRH)
Follicle Stimulating Hormone (FSH)
Lutenising Hormon (LH)
Estrogen
Progeterone
Secretory
Begins at ovulation and ends with menses
MENSTRUAL
ABNORMALITIES
Menorrhagia
Menorrhagia
Menorrhagia can be defined as a complaint
of
heavy cyclical menstrual blood loss over
several consecutive menstrual cycles in a
woman of reproductive years, or more
objectively, a total menstrual blood loss of
more than 80 ml per menstruation
(Hallberg et al, 1966).
Accompanied by other symptoms such as
menstrual pain (dysmenorrhoea)
Etiology
Hormonal disturbances, Ovarian dysfunction,
Drug therapy
Iron supplementation to treat anemia
Non-steroidal anti-inflammatories (NSAIDs) to treat
SURGERY
Non hysterectomy or interventional radiology
Endometrial abltion
Uterine artery embolitation
Hysteroscopic myomectomy
Hysterectomy
Hypomenorrhoea
Hypomenorrhoea
uterine bleeding of less than normal (less
Hormonal imbalance:
Uterine problems:
Therapy
As for as treatment ofHypomenorrheais
Polymenorrhea
Polymenorrhea
frequent menses
Uterine bleeding occurring at regular intervals
Oligomenorrhea &
Amenorrhea
Oligomenorrhea
reduction in frequency of menses
bleeding with menstrual intervals greater
than 35 days
Causes:
Menopause
OCP manipulation
Hypothalamic dysfunction
Chronic illness
Polycstic ovary
Amenorrhea
Amenorrhea absence of menses
Primary amenorrhea absence of menarche
Hypergonadotropic hypogonadism
Gonadal dysgenesis (i.e. Turner syndrome)
Premature ovarian failure
Hypogonadotropic hypogonadism
Constitutional delay of puberty
Congenital GnRH deficiency (Kallman syndrome)
Functional hypothalamic amenorrhea (i.e. Anorexia or Bulimia nervosa)
CNS tumor (i.e. Craniopharyngioma)
Normogonadotropic
Congenital (i.e. Mullerian agenesis, Androgen Insensitivity syndrome)
Outflow tract obstruction (i.e. Imperforate hymen, Transverse vaginal septum)
Hyperandrogenic anovulation (i.e. PCOS, Cushings disease)
dysgenesis 50%
Hypothalamic hypogonadism 20%
Absence of the uterus, cervix, or vagina 15%
Transverse vaginal septum or imperforate hymen
5%
Pituitary disease 5%
Association
Familial disorder
Constitutional delay of puberty
Turners syndrome
Symptoms of virilization?
PCOS
Ovarian or adrenal tumor
Presence of Y chromosome
Functional hypothalamic
amenorrhea
Hyperprolactinemia
Galactorrhea?
Hyperprolactinemia
Hypothalamic-pituitary disease
growth chart
Breast development (Tanner staging)
Evaluation for features of Turners syndrome
Webbed neck, low hair line, shield chest, widely spaced nipples
Tanner Stages
Stage 1: Prepubertal,
no palpable breast
tissue or pubic hair.
Stage 2:
Development of
breast bud; sparse,
straight pubic hair.
Stage 3: Enlargement
of breast; pubic hair
darker, coarser, and
curlier.
Stage 4: Areola and
papilla project above
the breast; pubic hair
adult-like in
appearance.
Stage 5: Recession of
areola to match
contour of breast;
pubic hair extends to
Figure from: Roede, MJ, van Wieringen, JC. Growth diagrams 1980: Netherlands
third nation-wide survey. Tijdschr Soc Gezondheids 1985; 63:1. Reproduced with
Yes
Yes
Perform
Perform ultrasound
ultrasound of
of
uterus
uterus
Measure
Measure FSH
FSH
FSH
FSH <
<
5
5
FSH
FSH >
>
20
20
Hypogonadotropi
Hypogonadotropi
c
c
hypogonadism
hypogonadism
Hypothalamic
Hypothalamic
Hypergonadotrop
Hypergonadotrop
ic
ic
hypogonadism
hypogonadism
amenorrhea
amenorrhea
Karyotype
Constitutional
Karyotype
Constitutional delay
delay
analysis
of
analysis
of puberty
puberty
Kallman
syndrome
Kallman syndrome
45,X
CNS
45,X
CNS tumor
tumor
46,XX
46,XX
O
O
Premature
Premature
ovarian
ovarian failure
failure
Turners
Turners
syndrome
syndrome
Uterus
Uterus
absent
absent or
or
abnormal
abnormal
Uterus
Uterus
present
present or
or
normal
normal
Karyotype
Karyotype
analysis
analysis
46,X
46,X
Y
Y
46,XX
46,XX
Androgen
Androgen
insensitivity
insensitivity
syndrome
syndrome
Mlleria
Mlleria
n
n
agenesi
agenesi
s
s
Outflow
Outflow
obstruction
obstruction
No
No
Yes
Yes
Imperforate
Imperforate
Evaluate
Evaluate for
for
hymen
hymen
2
amenorrhea
2
amenorrhea
Transverse
PCOS
Transverse vaginal
vaginal
PCOS
Cushing
Cushing
s
s
septum
septum
Secondary
Amenorrhea/Oligomenorrhea: Etiology
Pregnancy
Thyroid disease
Hyperprolactinemia
Prolactinoma
Breastfeeding, Breast stimulation
Medication (i.e. Antipsychotics, Antidepressants)
Hypergonadotropic hypogonadism
Postmenopausal ovarian failure
Premature ovarian failure
Hypogonadotropic hypogonadism
Functional hypothalamic amenorrhea (i.e. Anorexia or Bulimia nervosa)
CNS tumor (i.e. Craniopharyngioma)
Sheehans syndrome
Chronic illness
Normogonadotropic
Outflow tract obstruction (i.e. Ashermans syndrome, Cervical stenosis)
Hyperandrogenic anovulation (i.e. PCOS, Cushings disease, CAH)
Secondary
Amenorrhea/Oligomenorrhea: Etiology
Most common etiologies:
Ovarian disease 40%
Hypothalamic dysfunction 35%
Pituitary disease 19%
Uterine disease 5%
Other 1%
Secondary
Amenorrhea/Oligomenorrhea: History
Findings
Association
Functional hypothalamic
amenorrhea
PCOS
Cushings disease
Ovarian or adrenal tumor
Hyperprolactinemia
Chronic illness?
Functional hypothalamic
amenorrhea
Hypothalamic-pituitary disease
Galactorrhea?
Hyperprolactinemia
Sheehans syndrome
Ashermans syndrome
Secondary
Amenorrhea/Oligomenorrhea: Physical
Exam
General
Evaluation of height, weight, and BMI
Examine skin for hirsutism, acne, striae, acanthosis nigricans,
Thyroid exam
Breast exam
Express for galactorrhea
Pelvic exam
Atrophy
Vaginal dryness
Secondary
Amenorrhea/Oligomenorrhea:
Evaluation
Negative
Negative urine
urine pregnancy
pregnancy test
test
Check
Check TSH
TSH and
and prolactin
prolactin
Normal
Normal
prolactin,
prolactin,
Abnormal
Abnormal TSH
TSH
Both
Both
normal
normal
Progestin
Progestin challenge
challenge
test
test
Withdrawal
Withdrawal
bleed
bleed
Thyroid
Thyroid
disease
disease
No
No withdrawal
withdrawal bleed
bleed
Normogonadotropic
Normogonadotropic
hypogonadism
hypogonadism
Normal
Normal TSH,
TSH,
Abnormal
Abnormal
prolactin
prolactin
Prolactin
Prolactin <
< 100
100
ng/mL
ng/mL
Prolactin
Prolactin >
> 100
100
ng/mL
ng/mL
Medication
Medication
MRI
MRI to
to evaluate
evaluate
for
for
prolactinoma
prolactinoma
Estrogen/progestin
Estrogen/progestin
Challenge
Challenge test
test
Hyperandrogeni
Hyperandrogeni
c
c anovulation
anovulation
No
PCOS
No withdrawal
withdrawal bleed
bleed
PCOS
Cushings
Cushings
Outflow
Outflow
Ashermans
obstruction
obstruction
Ashermans
Cervical
Cervical
stenosis
stenosis
Negative
Negative MRI
MRI
Consider
Consider
other
other causes
causes
Withdrawal
Withdrawal
bleed
bleed
Check
Check FSH
FSH
Medication
Medication
FSH
FSH >
> 20
20
IU/L
IU/L
Hypergonadotrp
Hypergonadotrp
oic
oic
hypogonadism
Ovarian
Ovarian
hypogonadism
failure
failure
FSH
FSH <
< 5IU/L
5IU/L
MRI
MRI to
to evaluate
evaluate
for
pituitary
for pituitary
tumor
tumor
Hypothalam
Hypothalam
Normal
Normal MRI
MRI
ic
ic
Hypogonadotr
Hypogonadotr amenorrhea
amenorrhea
opic
opic
Chronic
Chronic
hypogonadism
hypogonadism illness
Secondary
Amenorrhea/Oligomenorrhea:
Evaluation
Progestin challenge test
Medroxyprogesterone acetate 10 mg daily for 10 days
IF withdrawal bleed occurs Not outflow tract
obstruction
IF no withdrawal bleed occurs Estrogen/Progestin
challenge test
days
Medroxyprogesterone acetate 10 mg daily for 26-35
days
IF no withdrawal bleed occurs Endometrial scarring
Secondary
Amenorrhea/Oligomenorrhea:
Evaluation
Evaluation of hyperandrogenism
Symptoms: hirsutism, acne, alopecia, masculinization, and
virilization
Differential diagnosis:
Adrenal disorders: Atypical congenital adrenal hyperplasia
(CAH), Cushings syndrome, Adrenal neoplasm
Ovarian disorders: PCOS, Ovarian neoplasms
Lab: Testosterone, DHEA-S, Indication
17-hydroxyprogesterone
Hormone
Level
Testosterone
DHEA-S
< 200
ng/dL
PCOS
> 200
ng/dL
< 700
ng/dL
PCOS
> 700
ng/dL
Amenorrhea/Oligomenorrhea:
Management
Treatment should be directed at
Correcting the underlying pathology
Helping woman to achieve fertility (IF desired)
Preventing the complications of disease process
Consequences of untreated
amenorrhea/oligomenorrhea:
Hypoestrogenism Osteoporosis, Infertility
Hyperestrogenism Heart disease, Stroke, Diabetes Mellitus,
Amenorrhea/Oligomenorrhea:
Management
Diagnosis
Management
Ovarian insufficiency
Premature ovarian failure
Postmenopausal ovarian failure
Surgical correction
Gonadectomy
Hyperprolactinemia
CNS tumor
Craniopharyngioma
Prolactinoma
Surgical resection
Microadenoma (< 10mm) Dopamine agonist
Macroadenoma (>10mm) Trans-sphenoidal
resection
PCOS
Ashermans syndrome
Dysmenorrhea
Dysmenorrhea
Dysmenorrhea
Dysmenorrhea severe, painful cramping
Primary Dysmenorrhea
Pathogenesis: Dysmenorrhea is thought to be
Secondary
Dysmenorrhea
Etiologies
Cervical Stenosis
Endometriosis and Adenomyosis
Pelvic Infection
Adhesions
Pelvic Congestion
Stress and Tension
Secondary
Dysmenorrhea
Cervical Stenosis
Secondary
Dysmenorrhea
Cervical Stenosis
Secondary
Dysmenorrhea
Pelvic Congestion
PRE-MENSTRUAL
SYNDROME
WHAT IS PMS:
It is a disorder characterized
TYPES OF PMS:
PMS-A: Anxiety, nervous
Types continued:
PMS-C: Cravings, for sweets,
CONTINUED:
High stress
After taking birth control or
DIET MAKES A
DIFFERENCE
ELIMINATE: Sugar, caffeine,
DIET CONTINUED:
AVOID: Salty and smoked
Treatment:
1. Eat small frequent meals 6x a
Continued:
5. Take PMS vitamins every
day
6. Try to relieve stress in your
life.
7. Stop Smoking!!!!
THANK YOU